VII. Are lymphomas driven by epigenetic lesions?

Hematol Oncol. 2015 Jun:33 Suppl 1:42-5. doi: 10.1002/hon.2215.
No abstract available

Keywords: B cell; CBP; EZH2; KMT2D; P300; clinical treatment strategies; epigenetic modifier mutations; epigenetic regulation; lymphoma.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Epigenesis, Genetic*
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Lymphoma / diagnosis
  • Lymphoma / genetics
  • Lymphoma / metabolism*
  • Lymphoma / pathology
  • Lymphoma / therapy
  • Male
  • Neoplasm Proteins / biosynthesis*
  • Neoplasm Proteins / genetics

Substances

  • Neoplasm Proteins